These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 31782436)
41. Dual-pH/Magnetic-Field-Controlled Drug Delivery Systems Based on Fe Hu X; Wang Y; Zhang L; Xu M; Zhang J; Dong W ChemMedChem; 2017 Oct; 12(19):1600-1609. PubMed ID: 28857472 [TBL] [Abstract][Full Text] [Related]
42. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance. Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418 [TBL] [Abstract][Full Text] [Related]
43. Mesoporous silica templated-albumin nanoparticles with high doxorubicin payload for drug delivery assessed with a 3-D tumor cell model. Ménard M; Meyer F; Parkhomenko K; Leuvrey C; Francius G; Bégin-Colin S; Mertz D Biochim Biophys Acta Gen Subj; 2019 Feb; 1863(2):332-341. PubMed ID: 30391506 [TBL] [Abstract][Full Text] [Related]
44. pH-Triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids. Muhammad F; Guo M; Qi W; Sun F; Wang A; Guo Y; Zhu G J Am Chem Soc; 2011 Jun; 133(23):8778-81. PubMed ID: 21574653 [TBL] [Abstract][Full Text] [Related]
45. Fluorescent carbon dot (C-dot) nanoclusters. Wang G; Pan X; Gu L; Ren W; Cheng W; Kumar JN; Liu Y Nanotechnology; 2014 Sep; 25(37):375601. PubMed ID: 25148433 [TBL] [Abstract][Full Text] [Related]
46. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation. Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639 [TBL] [Abstract][Full Text] [Related]
47. Acid and reduction stimulated logic "and"-type combinational release mode achieved in DOX-loaded superparamagnetic nanogel. Song M; Xue Y; Chen L; Xia X; Zhou Y; Liu L; Yu B; Long S; Huang S; Yu F Mater Sci Eng C Mater Biol Appl; 2016 Aug; 65():354-63. PubMed ID: 27157762 [TBL] [Abstract][Full Text] [Related]
49. Ultrasound-Enhanced Delivery of Doxorubicin-Loaded Nanodiamonds from Pullulan-all-trans-Retinal Nanoparticles for Effective Cancer Therapy. Li H; Ma M; Zhang J; Hou W; Chen H; Zeng D; Wang Z ACS Appl Mater Interfaces; 2019 Jun; 11(22):20341-20349. PubMed ID: 31082187 [TBL] [Abstract][Full Text] [Related]
50. Anticancer efficacy of photodynamic therapy with hematoporphyrin-modified, doxorubicin-loaded nanoparticles in liver cancer. Chang JE; Yoon IS; Sun PL; Yi E; Jheon S; Shim CK J Photochem Photobiol B; 2014 Nov; 140():49-56. PubMed ID: 25090224 [TBL] [Abstract][Full Text] [Related]
51. Quantum dots conjugated with Fe3O4-filled carbon nanotubes for cancer-targeted imaging and magnetically guided drug delivery. Chen ML; He YJ; Chen XW; Wang JH Langmuir; 2012 Nov; 28(47):16469-76. PubMed ID: 23131026 [TBL] [Abstract][Full Text] [Related]
52. mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect. Qin B; Liu L; Wu X; Liang F; Hou T; Pan Y; Song S Acta Biomater; 2017 Dec; 64():211-222. PubMed ID: 28963017 [TBL] [Abstract][Full Text] [Related]
53. A multifunctional nanocarrier based on nanogated mesoporous silica for enhanced tumor-specific uptake and intracellular delivery. Gao Y; Yang C; Liu X; Ma R; Kong D; Shi L Macromol Biosci; 2012 Feb; 12(2):251-9. PubMed ID: 22076739 [TBL] [Abstract][Full Text] [Related]
54. Simultaneous detection of dual proteins using quantum dots coated silica nanoparticles as labels. Qian J; Dai H; Pan X; Liu S Biosens Bioelectron; 2011 Oct; 28(1):314-9. PubMed ID: 21820890 [TBL] [Abstract][Full Text] [Related]
55. A graphene quantum dot@Fe Su X; Chan C; Shi J; Tsang MK; Pan Y; Cheng C; Gerile O; Yang M Biosens Bioelectron; 2017 Jun; 92():489-495. PubMed ID: 27839733 [TBL] [Abstract][Full Text] [Related]
56. Cytotoxicity of folic acid conjugated hollow silica nanoparticles toward Caco2 and 3T3 cells, with and without encapsulated DOX. Patel K; Sundara Raj B; Chen Y; Lou X Colloids Surf B Biointerfaces; 2016 Apr; 140():213-222. PubMed ID: 26764104 [TBL] [Abstract][Full Text] [Related]
57. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery. Ma X; Zhao Y; Ng KW; Zhao Y Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533 [TBL] [Abstract][Full Text] [Related]
58. Supramolecular stacking of doxorubicin on carbon nanotubes for in vivo cancer therapy. Liu Z; Fan AC; Rakhra K; Sherlock S; Goodwin A; Chen X; Yang Q; Felsher DW; Dai H Angew Chem Int Ed Engl; 2009; 48(41):7668-72. PubMed ID: 19760685 [No Abstract] [Full Text] [Related]
59. A self-targeting and controllable drug delivery system constituting mesoporous silica nanoparticles fabricated with a multi-stimuli responsive chitosan-based thin film layer. Chen C; Yao W; Sun W; Guo T; Lv H; Wang X; Ying H; Wang Y; Wang P Int J Biol Macromol; 2019 Feb; 122():1090-1099. PubMed ID: 30219514 [TBL] [Abstract][Full Text] [Related]
60. Hydrophobic end-gated silica nanotubes for intracellular glutathione-stimulated drug delivery in drug-resistant cancer cells. Wang L; Kim M; Fang Q; Min J; Jeon WI; Lee SY; Son SJ; Joo SW; Lee SB Chem Commun (Camb); 2013 Apr; 49(31):3194-6. PubMed ID: 23417143 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]